CHEN ISAN 4
4 · Mirati Therapeutics, Inc. · Filed Jan 22, 2019
Insider Transaction Report
Form 4
CHEN ISAN
Chief Medical & Dev't Officer
Transactions
- Award
Option Grant (Right to Buy)
2019-01-17+60,000→ 60,000 totalExercise: $64.14Exp: 2029-01-16→ Common Stock (60,000 underlying)
Holdings
- 34,966
Common Stock
- 110(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Includes 384 shares acquired under the ESPP Purchase on 11/30/18.
- [F2]1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.